Maybe. But, the initial results seemed very promising, and they have not been shy about drawing attention to their ongoing efforts in Covid.
They're continuing to expand their engagement with the medical community in using PLX with the compassionate use protocol. Pluristem clearly has to present evidence of efficacy to patients (families) and doctors, and if they cannot, they should just drop it, but they haven't.
So that does leave us with the question of why it's been so slow, especially when an early result would have enormous impact.
News 
Market Data 
Discover 
